These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 14768007)

  • 21. Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer.
    Szarvas T; Jäger T; Tötsch M; vom Dorp F; Kempkensteffen C; Kovalszky I; Romics I; Ergün S; Rübben H
    Clin Cancer Res; 2008 Dec; 14(24):8253-62. PubMed ID: 19088043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlations between cyclooxygenase-2 expression and angiogenic factors in primary tumors and liver metastases in colorectal cancer.
    Nakamoto RH; Uetake H; Iida S; Kolev YV; Soumaoro LT; Takagi Y; Yasuno M; Sugihara K
    Jpn J Clin Oncol; 2007 Sep; 37(9):679-85. PubMed ID: 17846040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
    Wada H; Nagano H; Yamamoto H; Yang Y; Kondo M; Ota H; Nakamura M; Yoshioka S; Kato H; Damdinsuren B; Tang D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Sakon M; Dono K; Wakasa K; Monden M
    Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association of the angiopoietin/Tie-2 system with the development of metastasis and leukocyte migration in neuroendocrine tumors.
    Figueroa-Vega N; Díaz A; Adrados M; Alvarez-Escolá C; Paniagua A; Aragonés J; Martín-Pérez E; Leskela S; Moreno-Otero R; González-Amaro R; Marazuela M
    Endocr Relat Cancer; 2010 Dec; 17(4):897-908. PubMed ID: 20696814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of VEGF-A and angiopoietins in cartilage tumors and regulation by interleukin-1beta.
    Kalinski T; Krueger S; Sel S; Werner K; Ropke M; Roessner A
    Cancer; 2006 May; 106(9):2028-38. PubMed ID: 16565972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular mechanism underlying angiogenesis in hepatocellular carcinoma: the imbalance activation of signaling pathways.
    Zhao ZC; Zheng SS; Wan YL; Jia CK; Xie HY
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):529-36. PubMed ID: 14627514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia.
    Paradis V; Bièche I; Dargère D; Laurendeau I; Nectoux J; Degott C; Belghiti J; Vidaud M; Bedossa P
    Gastroenterology; 2003 Mar; 124(3):651-9. PubMed ID: 12612904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of pro-angiogenic factors and their receptors on angiogenesis in hepatocellular carcinoma].
    Zhao ZC; Zheng SS; Wan YL; Jia CK; Li JJ; Gu JR; Guo BL
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):472-5. PubMed ID: 15555336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiopoietin-2 decreases vascular endothelial growth factor expression by modulating HIF-1 alpha levels in gliomas.
    Lee OH; Xu J; Fueyo J; Alonso MM; Liu D; Martin V; Jiang H; Piao Y; Liu TJ; Gomez-Manzano C
    Oncogene; 2008 Feb; 27(9):1310-4. PubMed ID: 17704802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization.
    Zeng W; Gouw AS; van den Heuvel MC; Zwiers PJ; Zondervan PE; Poppema S; Zhang N; Platteel I; de Jong KP; Molema G
    Hepatology; 2008 Nov; 48(5):1517-27. PubMed ID: 18924243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
    Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M
    Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in expression of angiopoietins and the Tie-2 receptor in the retina of streptozotocin induced diabetic rats.
    Ohashi H; Takagi H; Koyama S; Oh H; Watanabe D; Antonetti DA; Matsubara T; Nagai K; Arai H; Kita T; Honda Y
    Mol Vis; 2004 Aug; 10():608-17. PubMed ID: 15354084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of angiopoietin-2 and vascular endothelial growth factor in androgen-independent prostate cancer models.
    Tesan T; Gustavsson H; Welén K; Damber JE
    BJU Int; 2008 Sep; 102(8):1034-9. PubMed ID: 18489523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of tumor suppressor gene (p53) on brain tumor angiogenesis and expression of angiogenic modulators.
    Tse V; Yung Y; Santarelli JG; Juan D; Hsiao M; Haas M; Harsh G; Silverberg G
    Anticancer Res; 2004; 24(1):1-10. PubMed ID: 15015569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance.
    Tang D; Nagano H; Yamamoto H; Wada H; Nakamura M; Kondo M; Ota H; Yoshioka S; Kato H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Wakasa K; Monden M
    Oncol Rep; 2006 Mar; 15(3):525-32. PubMed ID: 16465407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain.
    Péoch M; Farion R; Hiou A; Le Bas JF; Pasquier B; Rémy C
    Anticancer Res; 2002; 22(4):2147-51. PubMed ID: 12174896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correlation between the expression of angiopoietins and their receptor and angiogenesis in gastric cancers].
    Zhang ZZ; Zhang S; Lin JY; Huang PS; Chen YP
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):280-4. PubMed ID: 16875629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma.
    Kuboki S; Shimizu H; Mitsuhashi N; Kusashio K; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Miyazaki M
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e157-64. PubMed ID: 17931370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Messenger RNA expression of vascular endothelial growth factor and its receptors in primary colorectal cancer and corresponding liver metastasis.
    Kobayashi H; Sugihara K; Uetake H; Higuchi T; Yasuno M; Enomoto M; Kuramochi H; Lenz HJ; Danenberg KD; Danenberg PV
    Ann Surg Oncol; 2008 Apr; 15(4):1232-8. PubMed ID: 18239970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential regulation of ANG2 and VEGF-A in human granulosa lutein cells by choriogonadotropin.
    Pietrowski D; Keck C
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):208-14. PubMed ID: 15127326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.